Blog articles

Base editing: What is it and what does it mean for healthcare?
This week, we take an in-depth look at the genome-editing technology that has been making headlines worldwide

Cancer therapy involving genome editing cures another child’s leukaemia
We look at a new type of CAR-T cell therapy that, in the world’s first use, has cured a child patient’s leukaemia

Genomics on the horizon: Three predictions for 2023
To kick off the new year, we look at three areas of genomics research and advancement to watch out for in 2023 and beyond

Looking back: Genomics in 2022 (part two)
In the second and final part of our round-up of 2022, we look back at some of the milestones reached this year in genomics research

Looking back: Genomics in 2022 (part one)
In the first of our two-part round-up of 2022, we look back at some of this year's most exciting clinical developments in genomics

Genetics tool for check-ups described as a 'game changer'
Including polygenic risk scores for heart disease has been found to be a useful addition to NHS health checks that doesn’t affect GP workload

Liquid biopsy: What is it and why does it matter?
We take a look at the blood test that researchers hope could lead to earlier diagnosis of cancer

Motor neurone disease: Could gene therapies be the answer?
New clinical studies hope to use genomics to improve treatment of and even find a cure for motor neurone disease

Achromatopsia gene therapy partially restores children’s colour vision
A new gene therapy for achromatopsia has partially restored colour vision in two children, according to new research

Confirmed: Covid-19 vaccine response depends on our genes
New research has revealed that the efficacy of the Covid-19 vaccine depends on our genome
News articles

New horizon-scanning webinar series for 2023
The GEP has launched the first of an exciting series of expert webinars designed to create a link between academia and genomics education
Events

LinkAGE Webinar 2: CRISPR
Welcome to the second of our new series of expert webinars. In this second webinar Dr James Patterson will discuss CRISPR.